Despite securing a much-needed $5 million lifeline from an equity offering this week, HCW Biologics is continuing to warn ...

COLUMBUS, Ohio--(BUSINESS WIRE)--Forge Biologics (“Forge”), a leading ... The Rejuva platform is in preclinical development and has not yet been evaluated by regulatory agencies for ...

HCW Biologics Inc. (the “Company”), (NASDAQ: HCWB), a clinical-stage biopharmaceutical company focused on discovering and ...

HCW Biologics Inc. (the "Company” or "HCW Biologics”) (NASDAQ: HCWB), a clinical-stage biopharmaceutical company focused on ...

HCW Biologics Inc. (the "Company" or "HCW Biologics") (NASDAQ: HCWB), a clinical-stage biopharmaceutical company focused on discovering and developing ...

ADC Therapeutics has culled its clinical asset ADCT-602 while announcing more data on its flagship drug Zynlonta ...

ROCKVILLE, Md., May 14, 2025 (GLOBE NEWSWIRE) -- Theriva™ Biologics (NYSE American: TOVX), a diversified clinical-stage ...

FibroBiologics, Inc. (Nasdaq: FBLG) (“FibroBiologics”), a clinical-stage biotechnology company with 240+ patents issued and pending with a focus on the development of therapeutics and potential cures ...

The transition from preclinical development to clinical trials is a critical, with approximately 89% of drugs failing. Nearly half of these failures stem from unexpected and unmanageable human ...

Creative Biolabs upgrades its therapeutic antibody and protein development platform, with enhanced capabilities in endotoxin ...

ADMA Biologics has surged 1,314% since 2021 with soaring revenue, ASCENIV demand, and strong financials. Learn why ADMA stock ...

Chime Biologics is a biologics service provider, from pre-clinical support and cell line development to clinical and commercial manufacturing of DS and DP.